| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $286K | -5.7% | -51.0% |
| Cost of Revenue | $141K | +69.9% | +129.9% |
| Gross Profit | $145K | -34.2% | -72.3% |
| R&D Expense | $323K | +23.5% | -13.2% |
| SG&A Expense | $1.3M | +1.3% | +5.7% |
| Operating Income | -$2.2M | -6.1% | -24.6% |
| Interest Expense | $0 | — | -100.0% |
| Pre-tax Income | -$2.2M | +27.1% | -24.7% |
| Net Income | -$2.2M | +27.1% | -24.7% |
| EPS (Basic) | -$0.07 | +36.4% | +22.2% |
| EPS (Diluted) | -$0.07 | +36.4% | +22.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Accounts Receivable | $30K | -78.4% | -93.9% |
| Inventory | $605K | +4.7% | +71.3% |
| Current Assets | $1.4M | -34.4% | +12.8% |
| Total Assets | $4.4M | -16.8% | +40.6% |
| Current Liabilities | $988K | -6.1% | -66.3% |
| Total Liabilities | $997K | -7.2% |
| Line Item | 2025-12-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$5.3M | — | — |
| Capital Expenditures | $8K | — | — |
| Investing Cash Flow | $12K | — | — |
| Financing Cash Flow | $5.1M | — | — |
| Free Cash Flow | -$5.3M | — | — |
| -73.8% |
| Stockholders' Equity | $3.4M | -19.2% | +586.3% |